Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Breast Diseases
Interventions: Supine automated breast ultrasound scanner, High-resolution handheld breast ultrasound; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 501 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Chicago, Illinois • Pittsburgh, Pennsylvania

Conditions: Bipolar Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Eye Movements, Attention, Executive Function
Interventions: Contour Search Task, Stop signal Task, Useful field of View, Attentional capture search task; Other · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Metastatic Ocular Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8
Interventions: Ipilimumab, Nivolumab, Pembrolizumab, Stereotactic Radiosurgery, Tumor Treating Fields Therapy; Biological · Radiation · Procedure
Lead sponsor: Emory University; Other
Eligibility: 22 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Brain Tumors, Epilepsy, Migraine, Mild Cognitive Impairment, Concussion, Multiple Sclerosis, Neuropathy, Parkinson's, Restless Legs Syndrome, Stroke
Interventions: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description); Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 3,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Hematologic Malignancy
Interventions: Thymoglobulin, Cyclophosphamide, Fludarabine, Thiotepa, Melphalan, Mesna, Filgrastim, Blinatumomab, CliniMACS; Drug · Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Alcohol Drinking, Alcohol Intoxication, Alcohol Use, Unspecified
Interventions: WayToServe Plus In-service Component, WayToServe Training Only; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Golden, Colorado

Conditions: Breast Cancer
Interventions: Molecular Breast Imaging, Conventional Mammography, Technetium (99mTc) sestamibi; Device · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years and older · Female only
Enrollment: 969 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Urinary Tract Infections
Interventions: Not listed
Lead sponsor: Pocared Diagnostics; Industry
Eligibility: Not listed
Enrollment: 40,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: North Hollywood, California • Rochester, Minnesota • Cleveland, Ohio + 1 more

Conditions: Neuroblastoma
Interventions: FLT-PET; Device
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 1 Day to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Stuttering, Adult
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Work-related Illness
Interventions: Pocket Ark; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Multiple Sclerosis
Interventions: Clinical Questionnaires, Semi-Structured Interviews, Ocrevus Zunovo; Other · Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rumination, Major Depressive Disorder, Anxiety
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: Anakinra; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Atrial Fibrillation (AF)
Interventions: Pulmonary Vein Isolation (PVI) without Left Atrial Posterior Wall Isolation (PWI), Pulmonary Vein Isolation (PVI) with Left Atrial Posterior Wall Isolation (PWI); Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Parkinson's Disease
Interventions: DNA/GeneticTesting, FDG PET scan, MRI scan, Clinical and neuropsychological assessments; Genetic · Radiation · Other
Lead sponsor: Northwell Health; Other
Eligibility: 40 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Sedentary Lifestyle
Interventions: Health Games Field Trial; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 11 Years to 15 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Prosthesis-Related Infections
Interventions: ABS deployed and active, ABS deployed and NOT active; Device
Lead sponsor: Nimbic Systems, LLC; Industry
Eligibility: 21 Years and older
Enrollment: 816 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Borderline Personality Disorder, Borderline Personality, BPD - Borderline Personality Disorder
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Glaucoma
Interventions: Not listed
Lead sponsor: Wills Eye; Other
Eligibility: 40 Years to 80 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Depressive Disorder, Major
Interventions: rTMS therapy; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Transcranial Magnetic Stimulation
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Tallahassee, Florida

Conditions: Diagnostic Imaging
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 99,999 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1984 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound

rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II

An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Quality Improvement and Practice Based Research in Neurology Using the EMR

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

WayToServePlus: Improving Responsible Alcohol Service Ph II

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

POCARED Diagnostics, LTD, Field Study Protocol

Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

Using Transcranial Magnetic Stimulation to Treat Stuttering

Agile Development of Innovative, Interactive Hazard Recognition and Mitigation Tools/Learning E-platforms for Workers Involved in Disaster Rescue and Recovery

Ocrevus Zunovo for MS: Mixed Methods

Decoding and Modulating Affective Brain States

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation

Genotypic Influences on Network Progression in Parkinson's Disease

Testing Health Games for Adolescent Physical Activity

Air Barrier System for the Prevention of Prosthesis-related Infections

Treatment of Borderline Personality Disorder With rTMS

Will Listening to Music Make it Easier to Take a Visual Field Test?

Biomarkers of Depression and Treatment Response

iTBS/fMRI Study of Apex Control

NMR Scanning on Patients